Global Medical REIT Reports Q2 Net Loss Amid Acquisition Moves
Global Medical REIT reports $3.1M net loss for Q2 2024. Key highlights include acquisitions and high portfolio occupancy despite challenges.
- Latest
- Trending
Global Medical REIT reports $3.1M net loss for Q2 2024. Key highlights include acquisitions and high portfolio occupancy despite challenges.
Disney and Super Micro's earnings failed investor expectations, causing stock drops. Warner Bros. Discovery's results are awaited.
SoundThinking reports a robust 22% revenue increase in Q2 2024, driven by ShotSpotter expansion and strategic partnerships.
Power Integrations sees a 16% Q2 revenue boost, driven by a 70% surge in consumer sales. GaN technology acquisition strengthens ...
BTB REIT reports mixed Q2 results with record occupancy but declining FFO per unit. Financial strategies and market shifts impact ...
Rhythm Pharmaceuticals sees robust Q2 2024 results with $29.1M revenues due to IMCIVREE's success in treating Bardet-Biedl syndrome.
DARPA's AI Cyber Challenge heats up, with healthcare sector keenly watching. $29.5m in prizes for the best AI systems tackling ...
Crexendo reports a 16% YoY revenue increase and a 220% rise in net income for Q2 2024, driven by strong ...
Veracyte's Q2 revenue surged 27% to $114.4M, fueled by strong demand for genomic tests. Full-year guidance raised to $432M-$438M.
Arbe Robotics secures contracts with major OEMs, anticipates revenue growth by 2025, despite current financial challenges.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.